Skip to content

Clinical trials

Phase 1 Hepatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 1 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20112
20124
20142
20151
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
ViiV Healthcare2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1
Christopher O'Brien, MD1
Dynavax Technologies Corporation1
Eiger BioPharmaceuticals1
GlaxoSmithKline1
GlobeImmune1
Mylan Inc.1
St. Jude Children's Research Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis13
Hepatitis B4
Acquired Immunodeficiency Syndrome2
Hepatitis C2
Infections2
Hepatitis D1
Hepatitis, Autoimmune1
Kidney Failure, Chronic1
Liver Cirrhosis1
Liver Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.